Gene · 8202
Papers3,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural proteomics defines a sequential priming mechanism for the progesterone receptor. | Nat Commun | 2025 | 40355435 | PubTator, text mining | PubMed |
| A model of thalamo-cortical interaction for incremental binding in mental contour-tracing. | PLoS Comput Biol | 2025 | 40338986 | PubTator, text mining | PubMed |
| Investigating the Impact of hsa_circ_0005255 on Proliferation and Autophagy in Crohn's Disease Intestinal Epithelial Cells Through miR-23a-3p-Mediated NCOA3 Expression. | Kaohsiung J Med Sci | 2025 | 40331881 | PubTator, text mining | PubMed |
| MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment. | NPJ Breast Cancer | 2025 | 40287441 | PubTator, text mining | PubMed |
| An Optimized Core Distribution Adaptive Topology Reconfiguration Algorithm for NoC-Based Embedded Systems. | Micromachines (Basel) | 2025 | 40283296 | PubTator, text mining | PubMed |
| Emd-D inhibited ovarian cancer progression via PFKFB4-dependent glycolysis and apoptosis. | Chin J Nat Med | 2025 | 40274346 | PubTator, text mining | PubMed |
| NCOA3 impairs the efficacy of anti-PD-L1 therapy via HSP90α/EZH2/CXCL9 axis in colon cancer. | Int Immunopharmacol | 2025 | 40215778 | PubTator, text mining | PubMed |
| Bufalin inhibits immune escape in metastatic colorectal cancer by regulating M2 macrophage polarization. | Apoptosis | 2025 | 40186793 | PubTator, text mining | PubMed |
| Hepatocyte TM4SF5-mediated cytosolic NCOA3 stabilization and macropinocytosis support albumin uptake and bioenergetics for hepatocellular carcinoma progression. | Exp Mol Med | 2025 | 40186033 | PubTator, text mining | PubMed |
| Sequence rules for a long SPOP-binding degron required for protein ubiquitylation. | Biochem J | 2025 | 40178506 | PubTator, text mining | PubMed |
| PFKFB4 promotes endometrial cancer by regulating glycolysis through SRC‑3 phosphorylation. | Oncol Rep | 2025 | 40116122 | PubTator, text mining | PubMed |
| DNA‑Directed Assembly of Photonic Nanomaterials for Diagnostic and Therapeutic Applications. | Adv Mater | 2025 | 40103431 | PubTator, text mining | PubMed |
| A long journey to the discovery of nuclear receptor coactivator existence, physiology, pathology, and therapy. | J Biol Chem | 2025 | 40090583 | PubTator, text mining | PubMed |
| Mechanism Study of Bufalin Reversal of Drug Resistance by Inhibiting Hypoxic Colon Cancer Cell-Induced Polarization of M2 Macrophages. | Integr Cancer Ther | 2025 | 40071641 | PubTator, text mining | PubMed |
| Sclerosis in Metastatic Uterine Tumor Resembling Ovarian Sex Cord Tumor: Diagnostic Dilemma Presented by Unusual Morphology. | Int J Gynecol Pathol | 2025 | 39982168 | PubTator, text mining | PubMed |
| Bufalin targets the SRC-3/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer. | J Cancer Res Clin Oncol | 2025 | 39921753 | PubTator, text mining | PubMed |
| Case Report: ESR1::CITED2 Fusion in a Malignant Uterine Tumor Resembling Ovarian Sex Cord Tumor. | Int J Gynecol Pathol | 2025 | 39869077 | PubTator, text mining | PubMed |
| FOXF2 expression triggered by endocrine therapy orchestrates therapeutic resistance through reorganization of chromatin architecture in breast cancer. | Cancer Lett | 2025 | 39828125 | PubTator, text mining | PubMed |
| MFIB 2.0: a major update of the database of protein complexes formed by mutual folding of the constituting protein chains. | Nucleic Acids Res | 2025 | 39526403 | PubTator, text mining | PubMed |
| Development of compact transcriptional effectors using high-throughput measurements in diverse contexts. | Nat Biotechnol | 2025 | 39487265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8202/papers?page=5